Complex Crystal Arthritis

Overview

The Complex Crystal Arthritis course offers a programme full of content for all rheumatology professionals.

Date: 17 January 2020

Venue: BCEC, Birmingham

CPD: 5

The course will provide delegates with an educational update on topics such as gout as well as the chance to exchange best practice with peers through an interactive discussion of challenging real-life clinical cases.

With a programme packed full of speakers who are leaders in their field of rheumatology, this is the perfect setting to learn from the experts and have the opportunity to ask those all-important questions.

Who should attend?

This one-day course is ideally suited to GPs, consultant rheumatologists, trainees and physicians in other specialties.

Objectives:

Awareness of latest evidence informing optimum urate-lowering therapy and learning how to achieve it in clinical practice
How to manage gout in patients with complex comorbidities such as chronic kidney disease, organ transplantation and cardiovascular disease
Awareness of therapeutic options for gout treatment (other than allopurinol) including febuxostat and uricosuric drugs
Understand role of ultrasound and dual-energy CT (DECT) in diagnosis of crystal arthritis, specific imaging features and diagnostic utility
Understand which metabolic conditions predispose to calcium pyrophosphate crystal deposition and which patients should be screened for these
Understand options for pharmacological management of complex calcium pyrophosphate crystal deposition

Book

Book your place now on our Complex Crystal Arthritis course

Member rates


Level 1 Consultant, allied specialty consultant, clinical academic and Pharma representatives	£195
Level 2 Rheumatology specialty trainee, foundation trainee, GP, non-clinical scientist, research fellow and specialty doctor	£145
Level 3 Health professional, nurse, charity representative, student and retired	£110

Prices do not include VAT, accommodation or travel.

Non-member rates


Level 1 Consultant, allied specialty consultant, clinical academic and Pharma representatives	£295
Level 2 Rheumatology specialty trainee, foundation trainee, GP, non-clinical scientist, research fellow and specialty doctor	£220
Level 3 Health professional, nurse, charity representative, student and retired	£165

Prices do not include VAT, accommodation or travel.

Programme

Friday 17 January

Morning sessions
09.15-14.00

Includes managing gout and uricosuric drugs sessions

Time	Session title
09.15-09.45	Refreshments
09.45-10.00	Welcome and introduction
10.00-10.30	Evidence-based urate-lowering therapy: what is it and how is it achieved?
10.30-11.15	Managing gout in chronic kidney disease and organ transplant recipients
11.15-11.45	Refreshments
11.45-12.15	Febuxostat: effectiveness and safety in clinical practice
12.15-12.45	Uricosuric drugs: when, how and which one?
12.45-13.15	Advanced imaging in crystal arthritis
13.15-14.00	Lunch

Afternoon sessions
14.00-16.00

Includes complex cases and panel discussion

Time	Session title
14.00-14.30	Metabolic predisposition in calcium pyrophosphate crystal deposition: who to screen, when and for what?
14.30-15.00	Pharmacological management of calcium pyrophosphate crystal deposition
15.00-16.00	Complex cases and panel discussion
16.00	Close

Complex Crystal Arthritis

Overview

The Complex Crystal Arthritis course offers a programme full of content for all rheumatology professionals.

Date: 17 January 2020

Venue: BCEC, Birmingham

CPD: 5

The course will provide delegates with an educational update on topics such as gout as well as the chance to exchange best practice with peers through an interactive discussion of challenging real-life clinical cases.

With a programme packed full of speakers who are leaders in their field of rheumatology, this is the perfect setting to learn from the experts and have the opportunity to ask those all-important questions.

Who should attend?

This one-day course is ideally suited to GPs, consultant rheumatologists, trainees and physicians in other specialties.

Objectives:

Awareness of latest evidence informing optimum urate-lowering therapy and learning how to achieve it in clinical practice

How to manage gout in patients with complex comorbidities such as chronic kidney disease, organ transplantation and cardiovascular disease

Awareness of therapeutic options for gout treatment (other than allopurinol) including febuxostat and uricosuric drugs

Understand role of ultrasound and dual-energy CT (DECT) in diagnosis of crystal arthritis, specific imaging features and diagnostic utility

Understand which metabolic conditions predispose to calcium pyrophosphate crystal deposition and which patients should be screened for these

Understand options for pharmacological management of complex calcium pyrophosphate crystal deposition

Book

Book your place now on our Complex Crystal Arthritis course

Member rates

Non-member rates

Programme

Friday 17 January

Morning sessions 09.15-14.00

Includes managing gout and uricosuric drugs sessions

Time

Session title

09.15-09.45

Refreshments

09.45-10.00

Welcome and introduction

10.00-10.30

Evidence-based urate-lowering therapy: what is it and how is it achieved?

10.30-11.15

Managing gout in chronic kidney disease and organ transplant recipients

11.15-11.45

Refreshments

11.45-12.15

Febuxostat: effectiveness and safety in clinical practice

12.15-12.45

Uricosuric drugs: when, how and which one?

12.45-13.15

Advanced imaging in crystal arthritis

13.15-14.00

Lunch

Afternoon sessions 14.00-16.00

Includes complex cases and panel discussion

Time

Session title

14.00-14.30

Metabolic predisposition in calcium pyrophosphate crystal deposition: who to screen, when and for what?

14.30-15.00

Pharmacological management of calcium pyrophosphate crystal deposition

15.00-16.00

Complex cases and panel discussion

16.00

Close

Programme and speakers are subject to change.

Morning sessions
09.15-14.00

Afternoon sessions
14.00-16.00